Thirty-month follow-up after intravitreal bevacizumab in progressive idiopathic macular telangiectasia type 2
2008 ◽
Vol 92
(7)
◽
pp. 941-945
◽
2013 ◽
Vol 23
(1)
◽
pp. 1-6
◽
2017 ◽
Vol 1
(6)
◽
pp. 415-419
◽